There are aproximately 25 laboratories at the MassGeneral Institute for Neurodegenerative Disease. Led by physician-scientists, certain labs collaborate and share resources on key projects to speed up the pace of discovering new treatments, and one day, we trust, find cures.

My laboratory is interested in the development and characterization of animal models of human neurodegenerative diseases, particularly Cerebral amyloid angiopathy (CAA), Alzheimer and Parkinson diseases.

The Kazantsev lab is focused on discovering therapeutic agents for Huntington's and Parkinson's diseases using high throughput screening, rational drug design, and medicinal chemistry lead optimization.